FP-253 (Beijing Foreland Biopharma)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFP-253 (Beijing Foreland Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 modulatorsImmunosuppressants
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsPsoriasisLupus Erythematosus, SystemicMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesForeland Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesForeland Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisLupus Erythematosus, SystemicMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A